More recent studies conducted in our laboratory has revealed IL-24 when expressed at pharmacological levels in human H1299 lung cancer cells inhibited the Akt/mTOR signaling pathway resulting in suppression of the tumor cell migratory function [48]. The gene discussed is AKT1; the disease is neoplasm.